JAMA Oncology
Brief Report
April 25, 2024
GiacomoMontagna,MD, MPH; Mary M.Mrdutt,MD, MS; Susie X.Sun,MD; CallieHlavin,MD, MPH; Emilia J.Diego,MD; Stephanie M.Wong,MD, MPH; Andrea V.Barrio,MD; Astrid Bottyvan den Bruele,MD; NeslihanCabioglu,MD, PhD; VaradanSevilimedu,MBBS, DrPH; Laura H.Rosenberger,MD, MS; E. ShelleyHwang,MD, MPH; AbigailIngham,MBchB; BärbelPapassotiropoulos,MD; Bich DoanNguyen-Sträuli,MD; ChristianKurzeder,MD; Danilo DíazAybar,MD; DeniseVorburger,MD; Dieter MichaelMatlac,MD; EdvinOstapenko,MD; FabianRiedel,MD; FlorianFitzal,MD; FrancescoMeani,MD; FranziskaFick,MD; JacquelineSagasser,MD; JörgHeil,MD, PhD; HasanKaranlık,MD; Konstantin J.Dedes,MD; LaszloRomics,MD, PhD; MaggieBanys-Paluchowski,MD, PhD; MahmutMuslumanoglu,MD; Maria Del Rosario CuevaPerez,MD; Marcelo ChávezDíaz,MD; MartinHeidinger,MD; Mathias K.Fehr,MD; MatteaReinisch,MD; MustafaTukenmez,MD; NadiaMaggi,MD; NicolaRocco,MD, PhD; NinaDitsch,MD, PhD; Oreste DavideGentilini,MD; Regis R.Paulinelli,MD, PhD; Sebastián SoléZarhi,MD; SherkoKuemmel,MD, PhD; SimonaBruzas,MD; Simonadi Lascio,MD; Tamara K.Parissenti,MD; Tanya L.Hoskin,MS; UweGüth,MD; ValentinaOvalle,MD; ChristophTausch,MD; Henry M.Kuerer,MD, PhD; Abigail S.Caudle,MD; Jean-FrancoisBoileau,MD, MSc; Judy C.Boughey,MD; ThorstenKühn,MD, PhD; MonicaMorrow,MD; Walter P.Weber,MD
online first
JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578
This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.
JAMA Surgery
Original Investigation
July 19, 2023
Walter P.Weber,MD; ZoltanMatrai,MD, PhD; StefanieHayoz,PhD; ChristophTausch,MD; GuidoHenke,MD; FrankZimmermann,MD; GiacomoMontagna,MD, MPH; FlorianFitzal,MD; MichaelGnant,MD; ThomasRuhstaller,MD; SimoneMuenst,MD; AndreasMueller,MD; LoïcLelièvre,MD; JörgHeil,MD; MichaelKnauer,MD, PhD; DanielEgle,MD; ÁkosSávolt,MD; MartinHeidinger,MD; ChristianKurzeder,MD; TAXIS Study Writing Group
open access
has multimedia
JAMA Surg. 2023; 158(10):1013-1021. 10.1001/jamasurg.2023.2840
This cohort study investigates the association between the omission of axillary dissection and systemic therapy in patients with clinically node-positive breast cancer in the postneoadjuvant setting.
JAMA Oncology
Brief Report
June 9, 2022
GiacomoMontagna,MD, MPH; JenniferZhang,MD; VaradanSevilimedu,MBSS, DrPH; JillianCharyn,BS; KellyAbbate,BS; Ethan A.Gomez,BS; BabakMehrara,MD; MonicaMorrow,MD; Andrea V.Barrio,MD
free access
JAMA Oncol. 2022; 8(8):1195-1200. 10.1001/jamaoncol.2022.1628
This cohort study evaluate rates and risk factors associated with breast cancer–related lymphedema in patients treated with axillary lymph node dissection.
JAMA Oncology
Brief Report
October 7, 2021
Andrea V.Barrio,MD; GiacomoMontagna,MD, MPH; AnitaMamtani,MD; VaradanSevilimedu,MBBS, DrPH; MarciaEdelweiss,MD; DeborahCapko,MD; Hiram S.CodyIII,MD; MahmoudEl-Tamer,MD; Mary L.Gemignani,MPH, MD; AlexandraHeerdt,MD; LaurieKirstein,MD; Tracy-AnnMoo,MD; MelissaPilewskie,MD; GeorgePlitas,MD; VirgilioSacchini,MD; LisaSclafani,MD; AudreeTadros,MD; Kimberly J.Van Zee,MS, MD; MonicaMorrow,MD
free access
JAMA Oncol. 2021; 7(12):1851-1855. 10.1001/jamaoncol.2021.4394
This cohort study examines nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy.